USV

USV Private Limited, commonly known as USV, is an Indian pharmaceutical and biotechnology company headquartered in Mumbai. The business was founded by Vithal Balkrishna Gandhi and has developed from an India-focused pharmaceutical operation into an international company serving markets in approximately 75 countries. It operates as a privately held enterprise and is associated with both pharmaceutical manufacturing and biotechnology-related research activities. USV’s principal technical focus is the development and manufacture of small-molecule active pharmaceutical ingredients, together with custom research services supporting drug development. This gives the company a role across several parts of the pharmaceutical value chain, including the development of chemical entities, production of active ingredients, and supply or commercialization of finished medicines. Its portfolio and market presence are particularly associated with treatments for diabetes and related metabolic conditions. The company is described as a leading producer of metformin in India. Metformin is a widely used oral medicine for type 2 diabetes, and USV’s prominence in this area is an important part of its Indian pharmaceutical identity. The company also participates in consumer-health and dermatological products: it produces and retails Sebamed products in India. In addition, USV markets selected products from Fujix Corp. outside Japan and the United States, giving it commercial relationships that extend beyond its own manufacturing and development activities. USV remains closely associated with the Gandhi family. Founder Vithal Balkrishna Gandhi’s granddaughter, Leena Tewari, is identified as chairperson, while Prashant Tewari serves as managing director. Their roles indicate the continuing importance of family leadership in the company’s governance and strategic direction. Public reference material does not establish a complete chronology of ownership, financial performance, product launches, or individual business-unit structures, so those details are not inferred here. The company’s positioning combines pharmaceutical manufacturing scale in India with international distribution, active-ingredient capabilities, and research services. Its business is broader than a single branded medicine: it includes prescription pharmaceuticals, ingredient development, contract or custom research, and selected consumer-health and partner-brand activities. Based on the available reference material, USV is active and internationally operating, but detailed current information about its full product portfolio, revenues, manufacturing footprint, and market-by-market operations is limited.

USV was established in India by Vithal Balkrishna Gandhi. The available reference material does not provide a verified founding year or a detailed sequence of the company’s early development, so its formative period cannot be dated more precisely here. The company is headquartered in Mumbai and has subsequently operated as an international pharmaceutical and biotechnology business. Over time, USV developed capabilities around small-molecule active pharmaceutical ingredients and custom research services for drug development. These activities place the company in both the manufacturing and research segments of the pharmaceutical industry. Rather than being limited to the sale of finished branded medicines, USV’s stated activities include work on the active ingredients that form the therapeutic basis of medicines and research support for pharmaceutical development. USV became particularly prominent in India as a producer of metformin. The medicine is a foundational treatment for type 2 diabetes, and this position connects the company with one of India’s largest and most established chronic-care therapeutic categories. The available material characterizes USV as a leading Indian producer of metformin but does not provide verified production volumes, market-share figures, or a dated account of how that position was achieved. The company also broadened its commercial scope through consumer-health and partner-brand activities. In India, USV produces and retails Sebamed products. It also markets certain Fujix Corp. products in global markets other than Japan and the United States. These relationships show that USV’s operating model includes distribution and commercialization arrangements alongside its own pharmaceutical and biotechnology activities. Leadership remains associated with the Gandhi family. Vithal Balkrishna Gandhi founded the company, and Leena Tewari, his granddaughter, is identified as chairperson. Prashant Tewari is identified as managing director. The business is described as operating across approximately 75 countries, although the available source does not list all markets, subsidiaries, facilities, or regional offices. USV is currently active and privately held. Publicly available reference material used for this entry does not establish a complete corporate timeline, detailed financial history, comprehensive product catalogue, or recent acquisition and regulatory chronology. Consequently, this history records only the company’s documented founding, capabilities, leadership, international reach, and principal commercial relationships.

A privately held Indian pharmaceutical and biotechnology company combining small-molecule drug development, active pharmaceutical ingredient manufacturing, custom research services, diabetes medicines, and selected consumer-health and partner-brand businesses.

• Diabetes pharmaceuticals

  Metformin medicines

  USV is identified as a leading producer of metformin in India. Metformin is an oral medicine widely used in the treatment of type 2 diabetes. The available reference material does not specify the complete range of USV metformin formulations, brand names, strengths, manufacturing sites, or launch dates.

• Pharmaceutical ingredients

  Active pharmaceutical ingredients

  USV focuses on the development of small-molecule active pharmaceutical ingredients, the chemically active components used in finished medicines. This capability supports the company’s own pharmaceutical activities and forms part of its broader technical and manufacturing offering. Specific ingredients beyond metformin are not identified in the available source material.

• Drug-development services

  Custom research services

  The company provides custom research services connected with drug development. These services are described at a high level and may support pharmaceutical research and development activities, but the available reference does not define the service catalogue, customer base, project stages, or commercial terms.

• Consumer health and dermatological products

  Sebamed products

  USV produces and retails Sebamed products in India. Sebamed is a dermatological and personal-care brand, and USV’s role gives it a presence in consumer health alongside prescription pharmaceuticals and biotechnology. The available material does not identify the specific Sebamed product ranges manufactured or distributed by USV.

• Partner-brand distribution

  Selected Fujix Corp. products

  USV markets some Fujix Corp. products in global markets outside Japan and the United States. This is a partner-brand commercialization activity rather than a fully described USV-owned product line. The available source does not specify the products, markets, agreement date, or distribution channels.

1. 1USVen.wikipedia.org
2. 2USV Private Limited official websiteusvindia.com